3billion Participates as a Panelist at ASGH 2025 in Hong Kong

3billion, a leader in AI-based genomic analysis for rare disease diagnostics, announced that CEO Changwon Keum will participate as a panelist at the Asia Summit on Global Health 2025 (ASGH 2025), taking place in Hong Kong from May 26th to 27th.

During the session on Addressing Unmet Needs: Orphan Drugs and Rare Disease Treatments, Keum will discuss improving the accessibility of rare disease diagnostics worldwide and enhancing diagnostic efficiency through AI technology.

The session will be moderated by Dr. Brian Chung from the University of Hong Kong and feature experts such as Prof. Dr. Jeffrey Beekman from Utrecht University Medical Center in the Netherlands, and Dr. Chen Yiwei from Wonder Sir in China.

Changwon Keum, a bioinformatics expert, has focused on advancing rare disease genomic analysis technologies and independently developed AI-based interpretation software. 3billion’s AI technology has significantly improved diagnostic accuracy and speed, enabling the company to provide rare disease diagnostic services in over 70 countries. The company has earned recognition for its technology in global AI challenges like CAGI6 and XcelerateRare, and has recently expanded its clinical partnerships with hospitals and pharmaceutical companies across Europe and the Middle East.

This participation in ASGH 2025 offers 3billion a chance to share its expertise and experience in rare disease diagnostics, while contributing to a broader discussion about the role of medical AI in solving critical global health challenges.

About ASGH 2025:

The Asia Summit on Global Health (ASGH) is the largest healthcare innovation and investment conference in Asia, co-hosted annually by the Hong Kong government and the Hong Kong Trade Development Council. Last year’s event attracted over 2,800 participants from more than 40 countries.

This year’s conference, under the theme Fostering Global Collaboration for a Shared Future, took place at the Hong Kong Convention and Exhibition Centre from May 26 to 27. It gathers industry leaders, government officials, and healthcare and bio sector professionals to explore industry trends and collaborative opportunities.